Exploratory Double-blind Placebo-controlled Study for the Assessment of Pharmacokinetics (PK), Safety, Tolerability, and Pharmacodynamics (PD) of Single Ascending Oral Doses of GLPG0974 in Healthy Subjects.
Phase of Trial: Phase I
Latest Information Update: 08 Feb 2016
At a glance
- Drugs GLPG 0974 (Primary)
- Indications Inflammatory bowel diseases
- Focus Pharmacokinetics
- Sponsors Galapagos NV
- 08 Feb 2016 Results of this and other trial (see profile 224323) published in the British Journal of Clinical Pharmacology
- 16 Oct 2013 Results will be presented at the United European Gastroenterology Week, according to a media release.
- 29 Feb 2012 New trial record